Get started

3m

3M Company (MMM) | Technically ready!3M Company (MMM) 3M is a multinational conglomerate that has operated since 1902, when it was known as Minnesota Mining and Manufacturing. The company is well known for its research and development laboratory and it leverages its science and technology across multiple product categories. As of 2020, 3M is organized into four business segments: safety and industrial, transportation and electronics, healthcare, and consumer. Nearly 50% of the company's revenue comes from outside the Americas, with the safety and industrial segment constituting a plurality of net sales. Many of the company's 60,000-plus products touch and concern a variety of consumers and end markets. A quite good dividend stock has arrived at the destination, hopefully :) MMM has come down from its all-time high of more than 60%. So, to buy this you need to make also a bit of work with fundamentals but technically, as said, it has arrived inside a possible buying zone. The technical criteria are: 1. Old resistance back in 2004 to 2012, starts to act as a support level. Yes, you can and actually you have to look back as far as possible to determine the strongest areas on the chart. The world has changed but human psychologic is still the same! 2. Mentioned many times that you have to keep an eye on the round numbers. Here is also the round number $100 and it matches with other criteria. 3. Channel projection, white lines. Typically the price moves inside the channels and sometimes it helps to find a decent support level. Currently, the projection runs nicely through the optimal buying zone. 4. Equal waves (AB=CD) and the D point, which completes the pattern, staying inside the buying zone. 5. All-time Fibonacci Golden ratio 62%. Basically draw from an all-time low to an all-time high and the Golden ratio is also there to add a bit of strength to the possible reversal area. Technically an optimal buying zone could be $80 - $102 First targets $135-$150 Good luck!
NYSE:MMMLong
by VaidoVeek
1
Analyzing the Good and Bad of 3M: Is It a Good Investment?When a company as renowned as 3M encounters difficulties, it's important to take a closer look at what's happening and why. While you may discover good news, there's also a chance you won't, but it's better to stay informed than to regret not paying attention. So, let's examine both the positive and negative aspects of 3M today. On the bright side, 3M has been increasing its dividend for more than six decades, making it one of the elite dividend kings. Additionally, the company's dividend yield of 5.8% is currently on the higher end of its historical range, which is a considerable draw for dividend investors. Moreover, with a consistent dividend growth rate of over 9% year-over-year for the past decade, it's easy to see why people might be interested in investing in the company's stock right now. In terms of traditional valuation metrics like price-to-earnings, price-to-sales, and price-to-book value, 3M remains an attractive investment option. All three metrics are hovering around their five-year averages, making the company a tempting investment opportunity. However, it's important to note that Wall Street rarely shorts stocks without a good reason. Dividends can also help provide insight into the company's performance. While the 10-year annual dividend growth rate for 3M is almost 10%, it's been declining in recent years. The average growth rate for the past five years has been just under 5%, with the average for the last three years being slightly over 1%. Furthermore, the most recent dividend increase was only 0.7%. This suggests that 3M's business has encountered adversity, and growth has slowed down. The most significant challenge 3M currently faces is legal and regulatory issues that won't be easily resolved. The most high-profile legal issue involves lawsuits related to earplugs sold to the military, with the company winning some cases and losing others. Recently, 3M has claimed that most of the plaintiffs aren't actually suffering from hearing loss. However, the lawsuit is expensive and likely to continue for some time. If 3M loses, the defeat could result in multi-billion dollar damages. Additionally, 3M is facing problems associated with producing "everlasting chemicals," which require costly efforts to clean up contaminated environments and may lead to years of litigation. The company plans to phase out production of these chemicals by 2025, which will result in expensive write-offs. This process will be challenging and costly. To make things even more complicated, 3M is planning to separate its medical business, which has long been viewed as a growth platform. Although this move may cause some concern, it would protect the business from liabilities that could impact the rest of the company's operations. Separating the medical business could also result in a higher price from Wall Street than if it were part of 3M. While this could be good news for shareholders, it does add complexity to the situation. Considering the long-term challenges 3M faces, it may not be a suitable investment for risk-averse investors due to the numerous company-specific concerns. However, it may make sense for more aggressive investors willing to take a bet on a company with an investment grade and a market capitalization of $50 billion, despite significant stock declines and legal and regulatory issues. Stocks don't enter the deep value zone for no reason, but investors must be prepared to weather the uncertainty if they decide to invest.
NYSE:MMMShort
by FOREXN1
3
3M Monthly Chart Signaling Further DownsideMMM has entered a downtrend on its monthly time frame. Downtrend was confirmed with a lower high in June of 2021, followed by a retest of strong support at 108 a share (which is also where the 200-day SMA currently sits). 3M may get a short-term bounce due to oversold reads on indicators, but this stock is clearly in a downtrend. The next big move in the medium term will be to the 62-69 support zone. Notice how there's virtually no support between 108-69. Good luck! This is not financial advice.
NYSE:MMMShort
by Gooby_Trades
4
3M is Near Bottom Valuation3M stock is considered very cheap as it is traded at 3.5x PB ratio. Even though the company has an decreasing future net income, it still has pretty strong revenue. 3M price is moving downward faster than it's strong fundamental. So it left room for potential upward gain, as it is now considered cheap in term of financial valuation. What is needed by the company is just a reduction of the cost and operate more efficiently. It that could be done I think 3M price could bounce up strongly. We are using Stock Value Rainbow to evaluate stock valuation based on four valuation metrices: book value, earning, dividend and cash flow. The rainbow color depict the multiples values of all these four factors sum up together. The rainbow above the gray lines represent 1x, 2x, 3x, .., 10x of stock value. While rainbow below the gray line represent 0.8x, 0.6x, 0.4x, 0.2x stock value. The higher the value the more expensive the stock, the lower the value the cheaper it is according to these fundamental or financial valuation metrices.
NYSE:MMM
by danny_peanuts
MMM 3M Company 141K Calls, $200 Strike Price, Expiring Sept. 16!I don`t know if you monitored the Option Chain last Friday. I always do that for my clients and I was shocked to see for MMM 3M Company 141K Calls with $200 Strike Price, Expiring Sept. 16! On Thursday we had 70K calls, same expiration date and strike price. It has to do something with 3M's Healthcare Spinoff which sees Roadblock from Veterans, which sued the company to block its planned spinoff of the healthcare business. I bet the call options buyers are thinking that the spinoff will be approved in court by September 16. The stock is one of the Dividend Kings, the company has increased its dividend for 65 years and the Forward Dividend & Yield id 5.96 (4.90%). At this oversold level, with the RSI at 22, i wouldn`t be surprised to see at least a technical bounce to $130, if not even higher. Looking forward to read your opinion about it!
NYSE:MMMLong
by TopgOptions
2
$MMM Longterm Investing OpportunityIs 3M currently a good Stock for a Dividendportfolio? NYSE:MMM $MMM is coming closer to a level where it's getting interesting for buy opportunities. The overall structure is still bullish on the monthly as well as on the weekly. The orderflow on the weekly is currently corrective as price is inside a very clean pullback (PB) The stock has been consolidating for the last weeks, which is a good sign because it is building liquidity on the bottom side, which we expect to get taken out before continuing to the upside. So from the technical side, we can start ticking the boxes if price sweeps the Liquidity that it is currently building up. From a fundamental perspective, 3M is getting closer to the fair value price, which is an additional confluence for me to open up long-term positions. It will be a good fit for my Dividendportfolio. I'll make an update if the stock makes significant changes in pricing.
NYSE:MMMLong
by Max_PowerFx
1
3M | Fundamental AnalysisThe continued poor performance of 3M stock indicates that investors are beginning to lose patience with the company. At the last investor presentation, management resigned from the full-year outlook it gave at the end of October. Thus, the company's stock is even falling out of favor with value-oriented investors and increasingly evolving an option only for dividend investors. Let's take a closer look at what's going on and whether 3M has investment potential. In early December, MMM CEO Mike Roman and CFO Monish Patolawala spoke at the Credit Suisse Industrial Companies Conference. They immediately told investors that organic sales growth in Q4 would be in the "lower half" of the expected growth range of zero to negative 2%. When a company lowers its sales estimates, it's never good news, but the update from 3M particularly disappointed investors. There are three reasons for this: First, the lower sales forecast came after management raised its full-year organic sales growth forecast in late October during its Q3 earnings presentation. In the third quarter, full-year organic sales growth was between 6% and 9%, but management noticed fit to increase the lower end of the range to 8%-9%, even as the full-year profit forecast was lowered to $9.70-$9.90 from $9.70 to $10.10. Considering that the assumed outlook for the fourth quarter has been lowered, investors are justifiably lowering earnings growth expectations. It also begs the question of why Patolawala decreased anticipations weeks after increasing them. Second, it's no secret that investors are watching 3M's margins closely for clues as to whether its restructuring measures are bringing operational improvements. Of course, it's much harder to judge this during a pandemic, but Patolawala has previously noted the significance of volume gain to 3M's margins. Given that sales growth will be weaker than expected, 3M's margins are likely to come under even more pressure in the fourth quarter. Third, management noted that it continues to experience supply shortages and high raw material costs. In other words, cost pressures will intensify in the fourth quarter. Consequently, 3M is seeking to raise prices so that the difference between price and raw material costs becomes margin neutral. At the conference, Patolawala was asked about pricing, to which he replied that investors should "wait and see" what prices 3M gets at the end of the quarter. The disappointing comments about pricing and the fact that 3M has not been able to offset rising costs with pricing actions call into question the company's business model and/or ability to execute it. For the record, 3M prides itself on investing heavily in research and development to produce differentiated products that have pricing power. Unfortunately, that pricing power is not apparent right now. Moreover, in recent years, company management has taken significant restructuring measures to improve performance. Indeed, during its third-quarter earnings call, Patolawala told investors that restructuring costs in 2021 would be between $300 million and $325 million, up from a previous forecast of $250 million to $300 million. Moreover, 3M management has restructured the business (business groups are now managed globally rather than by country) and the healthcare segment has been restructured through multibillion-dollar acquisitions and sales. So far, none of these restructuring actions has resulted in a noticeable improvement in growth or margins. Still, it's hard to be too critical of a company's management during a difficult trading period. In addition, Patolawala talked about the likelihood of improvements in volume growth, pricing, lower raw material costs, and the benefits of restructuring in the future. All of these factors point to higher margins in the future. In addition, 3M stock currently has a dividend yield of 3.5% and is well covered by free cash flow. Thus, the stock remains a good option for income-seeking investors. Finally, it relies on your investment profile. If you're looking for a relatively safe income source, 3M stock is a useful buy. However, poor operating performance and disappointing guidance will worry investors who prefer to see evidence of progress before buying. For those investors, it makes sense to wait and see what 3M reports in its subsequent earnings releases and what margin growth is projected for 2022.
NYSE:MMMLong
by FOREXN1
3
Post 10/26 Q3 FY21’ Earnings Analysis$MMM, $AMP, $GOOGL, $GE, $AMD, $COF, $HAS, $V, $TWTR, $UPS, $RTX, $NVS $MMM - 3M - reported EPS of $2,45/share - beat estimates of $2.21/share - revenue of $8.94B +7.09% YoY Organic local-currency sales up 6.3% YoY Operating CF of $1.9B Adjusted FCF of $1.5B (20%) YoY Returned $1.4B to shareholders in dividends Industrial FCF tops estimates Narrows FY21 EPS outlook - trims full-year earnings view on supply chain challenges Down (0.09%) after hours $GOOGL - Google Alphabet Class A - reported EPS of $27.26/share - beat estimates of $19.89/share Revenue of $53.62B Top Line growth of 44% Ad Revenue of $53.13B up 44% Revenue from Cloud Division of $4.99B up 45% Reported a $188M gain on investments up 623.1% YoY Down (0.22%) after hours $GE - General Electric - reported EPS of $0.57/share - beat estimates of $0.24/share - revenue of $18.43B down (0.5%) YoY Improvements in FCF performance & growth in earnings - despite weakness in revenues Bottom Line up 50% YoY Sales suffered from weakness in Healthcare & Renewable Energy segments - partially offset by gains in Aviation Organic & Industrial Revenues down (1%) YoY - Aviation Revenues up 10% YoY Up +0.01% after hours $AMD - Advanced Micro Devices - reported EPS of $0.73/share - beat estimates of $0.67/share - revenue of $4.31B up 54% YoY Adjusted Gross Margin of 48% - in line with estimates - up 44% YoY Capital Expenditures of $85M Computer/Graphics segment revenue of $2.4B up 44% YoY Q4 revenue estimates raised to $4.6B Down (0.41%) after hours $COF - Capital One - Reported EPS of $4686/share - beat estimates of $4.99/share - revenue of $7.83B +6.1% YoY Earnings Surprise of 31.42% Beat consensus EPS estimates past 4 quarters Revenue rise reflects loan growth Net credit card charge-offs improved in Sept Down (4.01%) after hours $HAS - Hasbro - reported EPS of $1.96/share - beat estimates of $1.70/share - revenue of $1.97B +10.88% YoY Operating Profit of $367.9M up 9% YoY Adjusted Operating Profit of $389.6M up 6% YoY Net Earnings of $253.2M up 15% YoY Adjusted Net Earnings of $271.2M up 5% YoY Supply chain challenges weigh on top line Further reduced debt & maintained a strong cash position - repaid $400M of debt & funded quarterly dividend Up +1.46% after hours $V - Visa - reported EPS of $1.62/share - beat estimates of $1.53/share - revenue of $6.56B up 27.45% YoY Earnings Surprise of 5.88% Surpassed consensus EPS estimates past 4 quarters Announce boost in quarterly dividend Down (2.60%) after hours $TWTR - Twitter - reported EPS of ($0.54) - missing estimates of $0.02/share - revenue of $1.28B up 37% YoY Reported a net loss of ($537M) vs. $29M in FY20' due to a legal settlement - does not expect to recoup the full revenue loss Ad Revenue rose more than 41% YoY to $4.14B up 6% YoY Number of Monetized users grew by 5M - user base up 13% YoY Apple's privacy changes to iOS 14 has less of an impact than expected $UPS - United Parcel Service - reported EPS of $2.71/share - beat estimates of $2.55/share - revenue of $23.18B US Domestic Package Revenues of $14.2B up 7.4% YoY Bottom Line up 18.9% YoY with strong performance across all segments Top Line up 9.2% YoY drive by up beat demand for e-commerce related package deliveries Operating Profit of $2.97B up 23.4% YoY Up +0.52% after hours $RTX - Raytheon Technologies - reported EPS of $1.26/share - beating estimates of $1.08/share - revenue of $16.2B up 7.7% YoY Sales of $16.2B - missing estimates of $16.9B - up 9.9% YoY Operating Profit of $1.3B - up 209.5% YoY Bottom Line up 125% YoY - attributable to higher YoY revenues & operating profit Newly disclosed quarterly dividend paid $0.51/share on 10/19/21 - represents a $2.04 dividend on an annualized basis Down (0.46%) after hours $NVS - Novartis - reported EPS of $1.71/share - beat estimates of $1.64/share - revenue of $13.03B up 6.2% YoY Net Income of $2.76B up 43% YoY Net Sales $13,03B up 6% YoY - volume contributed 9 percentage points to sales growth Down (1.38%) after hours
SP:SPX
by jnallain1
3M | Fundamental Analysis | Must Read...Industrial giant 3M will publish its Q3 earnings on Oct. 26. As always, quarterly earnings reports help shape investor thinking, whether it's near-term or long-term. Unfortunately, 3M management isn't likely to give investors much good news regarding near-term trends, but what about the long-term outlook? Here's what you should know before the earnings report comes out. The case for buying 3M is based on the idea that the significant free cash flow (FCF) generated by the company will give management the time and strength to turn around some of the volatile performance of recent years. Furthermore, based on that very FCF, the stock looks very favorable. If the company reaches Wall Street's consensus FCF forecast of $5.7 billion in 2021, it will trade at 18.2 times its FCF (current market capitalization is $104 billion). That's a pretty reasonable valuation for a mature industrial business proficient in increasing revenues at a rate not exceeding a single digit (in line with economic growth). If you add some margin expansion to this, and investors can expect a mix of stable earnings growth and dividend growth (current yield is 3.3%), then 3M is an excellent value investment option. However, the question is, where is 3M's profit margin headed? Gross profit margin (profit after cost of goods) is one of the best ways to measure a company's pricing power in the marketplace. While earnings margin before interest, taxes, depreciation, and amortization (EBITDA) also includes operating expenses and is a great way to measure how well a company is managed. 3M's performance has been questionable in recent years, and this is not due to the COVID-19 pandemic. In short, 3M needs to persuade investors that it can return the company to a long-term uptrend in margins. To that end, CEO Mike Roman restructured the business. The company is now managed from four operating segments rather than five, and business groups are now managed globally rather than by country. At the same time, management has undertaken restructuring expenses to streamline its operations. Moreover, management has invested in digital capabilities. The poorly performing healthcare segment has been restructured through divestitures and acquisitions, such as the $6.7 billion purchase of Acelity, a trauma business, and M*Modal, a $1 billion health information systems business; both deals were completed in 2019. So investors are right to sit back and say, "Show me margin expansion." But unfortunately, the COVID-19 pandemic has struck, and its distorting effects have made it much harder to see improvement, especially in terms of margin performance. Moreover, it is difficult to compare similar performance when the economy enters a period of downtime and resumption is impacted by soaring commodity prices and supply chain problems in key end markets. Moreover, many of the problems associated with resumption have worsened in 2021. As a result, the critical data most investors will be watching relates to the ratio of 3M's price to its cost of production. This is a critical metric for investors because 3M management prides itself on investing in innovation to produce differentiated products - in other words, products with pricing power. The dispute over whether 3M products are losing or gaining pricing power won't be resolved during the next earnings report, but we do know that pressure is building because of rising raw material costs and difficulties in the supply chain. For instance, CFO Monish Patolawala projected a $0 to $0.10 decline in earnings per share at the beginning of the year due to rising raw material prices. He later raised that forecast to $0.20, then to $0.30-$0.50 in April, and then to $0.65-$0.80 in July. Moving on to the Morgan Stanley Laguna Conference in mid-September, and Patolawala guided investors to the high end of the range. And that's without taking into account the impact on the supply chain of plant shutdowns during Hurricane Ida. Patolawala also said that inflation is outpacing 3M's ability to raise prices, and noted that auto production (a key end market for 3M) will be weaker than originally expected. In addition, the health care recovery has been uneven and the number of fee-for-service procedures is below management expectations, semiconductor shortages have impacted consumer electronics, and office resumption (3M sells office supplies) has been delayed. All point to a troubled earnings report. Still, much of the bad news should already be priced in, so don't be surprised if 3M stock rises if management's recommendations and comments turn out not to be so bad. Still, the earnings report is unlikely to do much good for long-term investors who are looking for convincing evidence that the turnaround attempts are working. Thus, 3M is likely to remain a good value stock, but with doubts surrounding it.
NYSE:MMMLong
by FOREXN1
1
Purchase of 3M in the continuation of the 5th wave of growthThe company is 3M (MMM). According to all estimates and proportions, now the price in 3M is in the 4th wave in the form of a triangle. The price is at the lower border of the triangle, there have already been false takeaways down. I propose to consider buying it in the continuation of the 5th wave with the goal of expanding on the first wave of Fibonacci 2.618, or 0.618 from the third wave. These Fibonacci levels coincide with the global maximum of January 2018, which also confirms their validity. The potential yield from the current price is 32 percent with the prospect of growth for about a year. Naturally , this is not an investment recommendation.
NYSE:MMMLong
by rvasilchenko